Paradigm Biopharmaceuticals Limited Share Price
Stocks
PAR
AU000000PAR5
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
07:10:26 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.2450 AUD | -2.00% |
|
-.--% | -27.94% |
| 10-08 | Paradigm Biopharmaceuticals Flags Missing Trial Data, Maintains Trading Suspension | MT |
| 10-08 | Paradigm Biopharmaceuticals Limited Provides Update on the Phase 3 Data | CI |
| Market Cap | 147M 103M 92.18M 85.17M 77.16M 144M 9.8B 1.02B 406M 5.13B 387M 379M 16.2B | P/E 2027 * |
-2.95x | P/E 2028 * | 1.35x |
|---|---|---|---|---|---|
| Enterprise Value | 135M 94.81M 84.64M 78.21M 70.85M 133M 9B 941M 373M 4.71B 356M 348M 14.88B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | -0.35x |
| Free-Float |
91.79% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PAR | Delayed | |
OTC Markets
| PBIGF | Delayed | |
|
Deutsche Boerse AG
| P86 | Delayed | |
|
Börse Stuttgart
| P86 | Delayed | |
|
Tradegate
| P86 | Real-time |
| 1 day | -2.00% | ||
| 3 months | +40.00% | ||
| 6 months | +8.89% | ||
| Current year | -27.94% |
| Current year | 0.14 |  | 0.37 |
| 1 year | 0.14 | | 0.47 |
| 3 years | 0.14 | | 0.66 |
| 5 years | 0.14 | | 2.69 |
| 10 years | 0.14 | | 4.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Rennie
CEO | Chief Executive Officer | - | 21/11/2022 |
| Director of Finance/CFO | - | 02/03/2023 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Rennie
CHM | Chairman | - | - |
Amos Meltzer
BRD | Director/Board Member | 60 | 08/12/2020 |
Matthew Fry
BRD | Director/Board Member | - | 03/03/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/06/26 | Buy | Chief Executive Officer | 176,470 | 0.0336% | ||
| 02/06/26 | Buy | Chief Executive Officer | 176,470 | 0.0336% | ||
| 02/06/26 | Buy | Chief Executive Officer | 176,470 | 0.0336% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.00% | -.--% | -45.56% | -62.88% | 103M | |
| +2.41% | -6.33% | +43.43% | +71.02% | 63.29B | |
| -0.15% | +3.11% | +10.29% | +72.56% | 54.89B | |
| +0.57% | +4.64% | +12.82% | +89.79% | 53.28B | |
| +0.37% | +3.07% | +28.23% | +51.53% | 45.81B | |
| -1.21% | +0.95% | +20.44% | +128.58% | 43.46B | |
| -0.37% | -1.20% | +252.94% | +568.54% | 40.23B | |
| +0.05% | +6.75% | +14.48% | +56.75% | 33.45B | |
| +1.19% | -5.84% | +27.86% | -0.65% | 23.7B | |
| -0.38% | +4.55% | +37.71% | +28.10% | 23.76B | |
| Average | +0.05% | +0.50% | +40.27% | +100.33% | 38.2B | |
| Weighted average by Cap. | +0.38% | +0.55% | +48.14% | +122.06% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 322M 226M 202M 187M 169M 317M 21.49B 2.25B 890M 11.26B 849M 831M 35.52B |
| Net income | -44.8M -31.51M -28.13M -25.99M -23.55M -44.1M -2.99B -313M -124M -1.57B -118M -116M -4.94B | 99.5M 69.98M 62.48M 57.73M 52.3M 97.94M 6.64B 695M 275M 3.48B 263M 257M 10.98B |
| Net Debt | -12M -8.44M -7.53M -6.96M -6.31M -11.81M -801M -83.78M -33.17M -420M -31.67M -31M -1.32B | -260M -183M -163M -151M -137M -256M -17.36B -1.82B -719M -9.09B -686M -672M -28.69B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- PAR Stock
Select your edition
All financial news and data tailored to specific country editions
